A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)
Clinical trial NCT05953740 · COMPLETED
Trial details
- NCT number
- NCT05953740
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2024-02-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.